Online signature company DocuSign's stock has underperformed this year, rising by just about 1% year-to-date, compared to the S&P 500 which is up by about 11% over the same period, as stronger Covid-19 vaccine deployment and lower new infection rates in the U.S. hurt work from home names...
Online signature company DocuSign's stock has underperformed this year, rising by just about 1% year-to-date, compared to the S&P 500 which is up by about 11% over the same period, as stronger Covid-19 vaccine deployment and lower new infection rates in the U.S. hurt work from home names...
Share this Article
Recommended